Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP559794.RAHoOY6SmpWBPon2nrVX7_oqN5n3yS0QzYen_4Kt4NhPI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP559794.RAHoOY6SmpWBPon2nrVX7_oqN5n3yS0QzYen_4Kt4NhPI130_assertion type Assertion NP559794.RAHoOY6SmpWBPon2nrVX7_oqN5n3yS0QzYen_4Kt4NhPI130_head.
- NP559794.RAHoOY6SmpWBPon2nrVX7_oqN5n3yS0QzYen_4Kt4NhPI130_assertion description "[Potent natural product-derived HIF-1 activators that exhibit a low level of toxicity and side effects hold promise as new treatment options for diseases such as myocardial and peripheral ischemia, and as chemopreventative agents that could be used to reduce the level of ischemia/reperfusion injury following heart attack and stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP559794.RAHoOY6SmpWBPon2nrVX7_oqN5n3yS0QzYen_4Kt4NhPI130_provenance.
- NP559794.RAHoOY6SmpWBPon2nrVX7_oqN5n3yS0QzYen_4Kt4NhPI130_assertion evidence source_evidence_literature NP559794.RAHoOY6SmpWBPon2nrVX7_oqN5n3yS0QzYen_4Kt4NhPI130_provenance.
- NP559794.RAHoOY6SmpWBPon2nrVX7_oqN5n3yS0QzYen_4Kt4NhPI130_assertion SIO_000772 16842166 NP559794.RAHoOY6SmpWBPon2nrVX7_oqN5n3yS0QzYen_4Kt4NhPI130_provenance.
- NP559794.RAHoOY6SmpWBPon2nrVX7_oqN5n3yS0QzYen_4Kt4NhPI130_assertion wasDerivedFrom befree-2016 NP559794.RAHoOY6SmpWBPon2nrVX7_oqN5n3yS0QzYen_4Kt4NhPI130_provenance.
- NP559794.RAHoOY6SmpWBPon2nrVX7_oqN5n3yS0QzYen_4Kt4NhPI130_assertion wasGeneratedBy ECO_0000203 NP559794.RAHoOY6SmpWBPon2nrVX7_oqN5n3yS0QzYen_4Kt4NhPI130_provenance.